• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD44 variant expression in inflammatory colonic mucosa is not disease specific but associated with increased crypt cell proliferation.

作者信息

Fromont Hankard G, Cezard J P, Aigrain Y, Navarro J, Peuchmaur M

机构信息

Department of Pathology, Robert Debré Hospital, Paris, France.

出版信息

Histopathology. 1998 Apr;32(4):317-21. doi: 10.1046/j.1365-2559.1998.00404.x.

DOI:10.1046/j.1365-2559.1998.00404.x
PMID:9602327
Abstract

AIMS

A recent study reported increased epithelial expression of CD44 variants in ulcerative colitis (UC) compared with Crohn's disease (CD). However, the use of CD44 expression for diagnostic purposes in inflammatory bowel disease has been controversial, and the meaning of the appearance of CD44 variants in epithelial colonic cells remains unknown. We investigated the relationship between CD44 isoform expression and crypt cell proliferation in paediatric colitis.

METHODS AND RESULTS

The expression of CD44v3, CD44v6, and MIB1 (proliferation marker) was studied by immunohistochemistry on surgical colonic samples of UC (n = 13), CD (n = 10), colostomy resections with non-specific mucosal inflammation (NSMI) (n = 3), and normal controls (N = 5). The proliferation index (% of MIB1 positive cells) was assessed in both v6 positive and v6 negative crypts. Epithelial expression of CD44v3 and v6, negative in normal controls, was variable and focal in colitis. No preferential expression of CD44 variants was found in UC. The proliferation index was dramatically increased in v6 positive crypts compared with v6 negative crypts in UC, CD and NSMI.

CONCLUSIONS

These data suggest that CD44 variant staining is not a useful marker for distinguishing paediatric UC from CD, and that CD44v6 expression in the inflamed colonic mucosa is not disease specific but is related to crypt cell proliferation.

摘要

相似文献

1
CD44 variant expression in inflammatory colonic mucosa is not disease specific but associated with increased crypt cell proliferation.
Histopathology. 1998 Apr;32(4):317-21. doi: 10.1046/j.1365-2559.1998.00404.x.
2
Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease.CD44v6和CD44v3在溃疡性结肠炎中表达增加,但在结肠克罗恩病中未出现这种情况。
Lancet. 1995 May 13;345(8959):1205-9. doi: 10.1016/s0140-6736(95)91991-0.
3
CD44v6 expression in inflammatory bowel disease is associated with activity detected by endoscopy and pathological features.炎症性肠病中CD44v6的表达与内镜检查所检测到的活动及病理特征相关。
Histopathology. 1999 Aug;35(2):144-9. doi: 10.1046/j.1365-2559.1999.00712.x.
4
CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Th1 and Th2 cytokines.结肠上皮细胞上的CD44异构体表达介导固有层淋巴细胞黏附,并受Th1和Th2细胞因子调控。
Eur J Gastroenterol Hepatol. 2003 Oct;15(10):1101-10. doi: 10.1097/00042737-200310000-00007.
5
Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.炎症性肠病中的肠道氧化损伤:半定量、定位及其与黏膜抗氧化剂的关联
J Pathol. 2003 Sep;201(1):28-36. doi: 10.1002/path.1409.
6
Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.结肠黏膜活检标本中Das-1和CG-3免疫组化表达的改变有助于区分溃疡性结肠炎与克罗恩病以及其他形式的结肠炎。
Am J Surg Pathol. 2008 Jun;32(6):844-50. doi: 10.1097/PAS.0b013e31815b121c.
7
[Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].[炎症性肠病患者肠黏膜中膜联蛋白A2的表达及其临床意义]
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Nov;32(11):1548-52.
8
Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.炎症性肠病患者肠黏膜中的细胞凋亡:FasL和穿孔素细胞毒性途径表达改变的证据
Int J Colorectal Dis. 2005 May;20(3):277-86. doi: 10.1007/s00384-004-0639-8. Epub 2004 Oct 22.
9
Alterations in mucosal content of colonic glycoconjugates in inflammatory bowel disease defined by monoclonal antibodies.用单克隆抗体定义的炎症性肠病中结肠糖缀合物黏膜含量的改变。
Gastroenterology. 1988 Aug;95(2):379-87. doi: 10.1016/0016-5085(88)90494-5.
10
Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease.从对照个体和炎症性肠病患者中分离出的隐窝上皮细胞、假定干细胞和肠道肌成纤维细胞中Toll样受体的表达。
Clin Exp Immunol. 2014 Oct;178(1):28-39. doi: 10.1111/cei.12381.

引用本文的文献

1
CD44 as a Central Integrator of Inflammation and Fibrosis: From Molecular Signaling to Environmental Modulation.CD44作为炎症和纤维化的核心整合因子:从分子信号传导到环境调节
Int J Mol Sci. 2025 Sep 11;26(18):8870. doi: 10.3390/ijms26188870.
2
Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease.具有增强抗氧化活性的金纳米颗粒负载二氧化铈用于治疗炎症性肠病。
Bioact Mater. 2023 Jan 26;25:95-106. doi: 10.1016/j.bioactmat.2023.01.015. eCollection 2023 Jul.
3
Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages.
透明质酸偶联聚乳酸-羟基乙酸共聚物纳米粒通过CD44介导的对炎症性结肠组织和巨噬细胞的双重靶向作用减轻溃疡性结肠炎
Pharmaceutics. 2022 Oct 5;14(10):2118. doi: 10.3390/pharmaceutics14102118.
4
Novel drug delivery systems for inflammatory bowel disease.新型炎症性肠病药物递送系统。
World J Gastroenterol. 2022 May 14;28(18):1922-1933. doi: 10.3748/wjg.v28.i18.1922.
5
Modulation of Gut Barrier Functions in Ulcerative Colitis by Hyaluronic Acid System.透明质酸系统对溃疡性结肠炎肠道屏障功能的调节。
Adv Sci (Weinh). 2022 Feb;9(4):e2103189. doi: 10.1002/advs.202103189. Epub 2021 Nov 10.
6
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.口服纳米医学调节免疫、肠道屏障功能和肠道微生物组。
Adv Drug Deliv Rev. 2021 Dec;179:114021. doi: 10.1016/j.addr.2021.114021. Epub 2021 Oct 26.
7
Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies.用于治疗炎症性肠病的受体介导靶向给药系统:机遇与新策略
Acta Pharm Sin B. 2021 Sep;11(9):2798-2818. doi: 10.1016/j.apsb.2020.11.003. Epub 2020 Nov 7.
8
Exploitation of Marine-Derived Robust Biological Molecules to Manage Inflammatory Bowel Disease.海洋衍生的强韧生物分子在炎症性肠病管理中的应用。
Mar Drugs. 2021 Mar 30;19(4):196. doi: 10.3390/md19040196.
9
New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy.口服结肠递药系统治疗炎症性肠病的新视角
Int J Mol Sci. 2020 Sep 5;21(18):6502. doi: 10.3390/ijms21186502.
10
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.通过透明质酸功能化纳米颗粒口服靶向递送三肽KPV可有效缓解溃疡性结肠炎。
Mol Ther. 2017 Jul 5;25(7):1628-1640. doi: 10.1016/j.ymthe.2016.11.020. Epub 2017 Jan 28.